24 May 2013
Keywords: insmed, shares, soar, news, od, designation, iplex
Article | 19 December 2005
US drugmaker Insmed Inc says that the Food and Drug Administration has approved Iplex (mecasermin rinfabate (rDNA origin) injection) for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 2005
© 2013 thepharmaletter.com